ABX three-lens brief
Evidence-based stock research on ABX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 12.2pp over 30 days.
- Outperforming SPY by 12.2pp over 30 days.
- Analyst mean target $13.75 — 53% above current (6 analysts).
- Reported earnings on 2026-11-05.
ABX closed at $9.01 (-1.31%) as of 2026-11-12. Market cap: $880.56M. P/E (trailing) 25.7. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 12.2pp over 30 days.; analyst mean target $13.75 — 53% above current (6 analysts).. Last quarter: Revenue $76.88M, net income $14.52M.
Why three lenses on ABX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ABX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABX brief"></iframe>